NCT02162862View on ClinicalTrials.gov

Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Sleep DisturbanceFatigueInflammatory Bowel Disease
Interventions
BEHAVIORAL

Behavioral Counseling

DRUG

bupropion-SR

Trial Locations (2)

15213

Presbyterian University Hospital of UPMC, Pittsburgh

15224

Children's Hospital of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

lead

Eva Szigethy

OTHER

NCT02162862 - Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter